Clinical Trial

Point-of-care Capillary HbA1c Testing for Type 2 Diabetes Screening Among At-risk Individuals in Rural Dali, China

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This project aims to compare Point-of-care capillary HbA1c (POC-cHbA1c) testing and fingerstick random blood glucose (RBG) testing in terms of type 2 diabetes detection rate and cost-effectiveness, in order to optimise current screening strategies for rural populations at high risk of diabetes in rural Dali, China, and to improve treatment adherence and self-management among people with diabetes.
Trial Details
NCT Number NCT07718867
Lead Sponsor The University of Hong Kong
Conditions Type 2 Diabetes, Pre-diabetes
Enrollment 720 participants
Start Date 2026-07-28
Primary Completion 2027-07-31 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-28